A Study to Examine APL-130277 in Patients With Parkinson's Disease

NCT02228590 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sumitomo Pharma America, Inc.